2273.HK
Gushengtang Holdings Limited
HKSEHKDEQUITY
Healthcare
DELAYED
Last price
26.58
▼ 0.36 (1.34%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
27.04
Prev close
26.94
Day high
27.04
Day low
26.32
Volume
342.20K
Market cap
$5.63B
P/E (TTM)
15.73
52W range
24.32 – 34.20
Day trading desk
Gap from prior close
+0.37%
Prior close 26.94
VWAP
26.47
+0.41% from price
Relative volume
1.12×
Normal
Session range
2.81%
26.30 – 27.04
Position in range
38%
Mid range
ATR (14D)
0.79
2.98% of price
Prior day high
27.38
PDH
Prior day low
26.66
PDL
Bid / ask spread
—
Quote not published
Session volume
1.13M
Avg 1.01M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.28%
-1.2%
1M
-6.21%
-9.6%
3M
-0.97%
-3.4%
6M
-14.92%
-26.9%
YTD
-4.94%
-17.0%
1Y
-20.89%
-41.1%
3Y
-46.95%
-122.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 2273.HK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
102.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Apr 29, 26 | Tu (Zhiliang) Chief Executive Officer |
BUY | 75.00K | $285.59K | Direct |
| Apr 28, 26 | Tu (Zhiliang) Chief Executive Officer |
BUY | 61.50K | $235.72K | Direct |
| Apr 23, 26 | Tu (Zhiliang) Chief Executive Officer |
BUY | 66.70K | $249.52K | Direct |
| Apr 22, 26 | Tu (Zhiliang) Chief Executive Officer |
BUY | 67.00K | $249.09K | Direct |
| Jan 28, 26 | Tu (Zhiliang) Chief Executive Officer |
BUY | 227.50K | $879.79K | Direct |
| Jan 27, 26 | Tu (Zhiliang) Chief Executive Officer |
BUY | 7.50K | $29.33K | Direct |
| Nov 19, 25 | Tu (Zhiliang) Chief Executive Officer |
OTHER | 106.00K | $398.62K | Direct |
| Nov 18, 25 | Tu (Zhiliang) Chief Executive Officer |
OTHER | 100.00K | $385.08K | Direct |
| Nov 17, 25 | Tu (Zhiliang) Chief Executive Officer |
OTHER | 270.00K | $1.05M | Direct |
| Apr 9, 25 | Tu (Zhiliang) Chief Executive Officer |
— | 2.82M | — | Direct |
| Apr 3, 25 | Tu (Zhiliang) Chief Executive Officer |
OTHER | 50.00K | $202.28K | Direct |
| Apr 1, 25 | Tu (Zhiliang) Chief Executive Officer |
OTHER | 100.00K | $436.30K | Direct |
| Jan 24, 25 | Tu (Zhiliang) Chief Executive Officer |
OTHER | 30.00K | $104.55K | Direct |
| Jan 23, 25 | Tu (Zhiliang) Chief Executive Officer |
OTHER | 49.10K | $168.67K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Tu (Zhiliang) |
Chief Executive Officer | 73.17M | Acquisition |
Fundamentals
Market cap$5.63B
Enterprise value$6.07B
Revenue (TTM)$3.25B
Gross profit$1.01B
EBITDA$485.74M
Net income$352.76M
EPS (TTM)$1.69
Free cash flow$497.18M
Total cash$1.05B
Total debt$784.01M
Book value / share$10.76
Shares outstanding211.90M
Float164.40M
Short % of float—
Dividend yield3.86%
Beta (5Y)0.59
Valuation & profitability ratios
Trailing P/E15.73
Forward P/E10.13
PEG ratio—
Price / sales—
Price / book2.47
EV / revenue1.87
EV / EBITDA12.49
Gross margin31.16%
Operating margin14.14%
Profit margin10.86%
Return on equity15.44%
Return on assets6.93%
Debt / equity35.89
Current ratio1.61
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.25B | $3.02B | $2.32B | $1.62B | +7.5% |
| Operating revenue | $3.25B | $3.02B | $2.32B | $1.62B | +7.5% |
| Cost of revenue | $2.24B | $2.11B | $1.62B | $1.13B | +5.9% |
| Gross profit | $1.01B | $909.35M | $700.00M | $499.54M | +11.3% |
| Selling, general & admin | $564.34M | $553.38M | $436.08M | $307.54M | +2.0% |
| Total operating expense | $551.19M | $543.78M | $421.10M | $295.76M | +1.4% |
| Operating income | $461.22M | $365.56M | $278.90M | $203.77M | +26.2% |
| Net interest income | -$10.49M | $7.38M | -$7.10M | -$3.56M | -242.1% |
| Pre-tax income | $423.65M | $363.27M | $284.17M | $198.71M | +16.6% |
| Tax provision | $71.58M | $56.10M | $31.23M | $17.56M | +27.6% |
| Net income | $352.76M | $306.78M | $252.20M | $180.85M | +15.0% |
| Net income to common | $352.76M | $306.78M | $252.20M | $180.85M | +15.0% |
| Basic EPS | 1.49 | 1.26 | 1.06 | 0.79 | +18.3% |
| Diluted EPS | 1.45 | 1.22 | 1.03 | 0.76 | +18.9% |
| EBIT | $449.80M | $380.89M | $309.75M | $216.32M | +18.1% |
| EBITDA | $637.54M | $531.87M | $429.90M | $324.22M | +19.9% |
| Basic shares | 237.36M | 243.00M | 237.54M | 230.27M | -2.3% |
| Diluted shares | 242.47M | 251.02M | 244.23M | 239.05M | -3.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $882.33M | $1.12B | $1.30B | $994.33M | -21.0% |
| Cash & short-term investments | $1.10B | $1.14B | $1.33B | $1.02B | -3.3% |
| Accounts receivable | $257.40M | $269.44M | $179.93M | $89.41M | -4.5% |
| Inventory | $194.54M | $179.49M | $152.95M | $104.86M | +8.4% |
| Total current assets | $1.86B | $1.81B | $1.84B | $1.36B | +2.4% |
| Property, plant & equipment | $664.87M | $556.14M | $467.38M | $339.33M | +19.6% |
| Goodwill & intangibles | $1.36B | $1.15B | $1.04B | $844.43M | +17.8% |
| Total assets | $3.99B | $3.66B | $3.38B | $2.62B | +9.2% |
| Total current liabilities | $1.15B | $763.31M | $708.23M | $554.32M | +50.9% |
| Current debt | $118.22M | $7.88M | $16.43M | $18.21M | +1,399.3% |
| Long-term debt | $188.49M | $92.20M | $0 | $52.96M | +104.4% |
| Total debt | $784.01M | $508.56M | $370.57M | $351.29M | +54.2% |
| Total liabilities | $1.81B | $1.28B | $1.07B | $900.25M | +41.3% |
| Retained earnings | -$786.00M | -$1.14B | -$1.41B | -$1.58B | +30.8% |
| Shareholder equity | $2.17B | $2.38B | $2.30B | $1.72B | -8.7% |
| Working capital | $704.14M | $1.05B | $1.13B | $805.29M | -32.9% |
| Net tangible assets | $810.35M | $1.22B | $1.27B | $872.46M | -33.7% |
| Shares issued | 234.37M | 243.71M | 246.30M | 230.40M | -3.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $423.65M | $363.27M | $284.17M | $198.71M | +16.6% |
| Depreciation & amortisation | $187.74M | $150.98M | $120.16M | $107.89M | +24.3% |
| Stock-based compensation | $50.49M | $93.19M | $51.77M | $17.25M | -45.8% |
| Change in working capital | -$31.91M | -$140.16M | -$39.83M | -$49.91M | +77.2% |
| Operating cash flow | $612.42M | $452.37M | $410.14M | $281.00M | +35.4% |
| Capital expenditure | -$118.45M | -$90.61M | -$77.73M | -$37.51M | -30.7% |
| Investing cash flow | -$377.58M | -$267.37M | -$263.61M | -$178.36M | -41.2% |
| Share buybacks | -$431.93M | -$255.28M | -$39.37M | $0 | -69.2% |
| Dividends paid | -$163.47M | -$28.26M | -$89.76M | — | -478.4% |
| Financing cash flow | -$464.46M | -$375.19M | $157.50M | -$138.08M | -23.8% |
| Free cash flow | $493.97M | $361.77M | $332.41M | $243.49M | +36.5% |
| End cash position | $882.33M | $1.12B | $1.30B | $994.33M | -21.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $882.33M | $1.16B | $1.12B | -23.8% |
| Cash & short-term investments | $1.10B | $1.28B | $1.14B | -13.9% |
| Accounts receivable | $257.40M | $208.47M | $269.44M | +23.5% |
| Inventory | $194.54M | $190.55M | $179.49M | +2.1% |
| Total current assets | $1.86B | $1.93B | $1.81B | -3.8% |
| Property, plant & equipment | $664.87M | $583.10M | $556.14M | +14.0% |
| Goodwill & intangibles | $1.36B | $1.18B | $1.15B | +14.9% |
| Total assets | $3.99B | $3.89B | $3.66B | +2.6% |
| Total current liabilities | $1.15B | $866.78M | $763.31M | +32.9% |
| Current debt | $118.22M | $14.27M | $7.88M | +728.7% |
| Long-term debt | $188.49M | $188.89M | $92.20M | -0.2% |
| Total debt | $784.01M | $639.75M | $508.56M | +22.5% |
| Total liabilities | $1.81B | $1.51B | $1.28B | +19.6% |
| Retained earnings | -$786.00M | -$1.07B | -$1.14B | +26.8% |
| Shareholder equity | $2.17B | $2.38B | $2.38B | -8.8% |
| Working capital | $704.14M | $1.06B | $1.05B | -33.7% |
| Net tangible assets | $810.35M | $1.20B | $1.22B | -32.2% |
| Shares issued | 234.37M | 236.41M | 243.71M | -0.9% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | 1.93 | 9 | $3.80B | +16.9% |
| Next year | 2.25 | 9 | $4.38B | +15.4% |
Analyst targets & ownership
Mean target$40.47
High target$59.51
Low target$25.02
Implied upside52.25%
Analyst count17
ConsensusSTRONG BUY
Strong buy / Buy3 / 15
Hold0
Sell / Strong sell1 / 0
Held by insiders43.90%
Held by institutions17.22%
Institutions holding58
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
27.01
-1.60% from price
SMA 20
27.86
-4.60% from price
SMA 50
28.24
-5.86% from price
SMA 100
28.12
-5.49% from price
SMA 200
28.57
-6.95% from price
EMA 12
27.27
-2.53% from price
EMA 26
27.81
-4.42% from price
EMA 50
28.06
-5.28% from price
RSI (14)
37.0
Neutral
MACD (12,26,9)
-0.54
Hist -0.11
ATR (14)
0.79
2.98% of price
Realised vol 30D
29.3%
Annualised
Bollinger upper
29.82
20, 2σ
Bollinger lower
25.91
20, 2σ
50 / 200 cross
Death
28.24 vs 28.57
Trend bias
Below 200
-6.95%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.12
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
29.3%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-25.6%
Peak to trough
Max drawdown 5Y
-58.1%
Peak to trough
ATR 14
0.79
2.98% of price
Beta (reported)
0.59
5Y monthly, from filing
Dividends & splits
Forward rate$1.04 / yr
Forward yield3.86%
5-year avg yield—
Payout ratio47.92%
Ex-dividend dateJun 24, 2026
Next pay date—
Last split—
Split date—
Headlines
Applied Biologics CEO and Former Marine F/A-18 Pilot Edward Britt Selected as Honorary Commander at Luke Air Force Base
GlobeNewswire · 4m ago
Down 40% on AI Pressure, Michael Burry Says Alibaba Needs to Still Fall by Half
24/7 Wall St. · 6m ago
Prime Minister Carney participates in a virtual meeting in support of Ukraine
CNW Group · 6m ago
Transactions in connection with share buyback programme
GlobeNewswire · 6m ago
Dan Ives Says Investors Still Underestimate Nvidia Days Before Earnings
24/7 Wall St. · 6m ago
LV Collective Delivers Rambler Tempe Near Arizona State University
GlobeNewswire · 7m ago
Heimstaden Bostad AB (publ) Issues SEK 1,500 Million Green Notes in Multiple Tranches
GlobeNewswire · 7m ago
NorthPalm Commits Entire Cybeats Position to a 12-Month Lock-Up; 60 Million Shares Representing Approximately 30% of Cybeats
TMX Newsfile · 8m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.